
    
      Through the integration of two technologies, pharmacokinetics and comprehensive evaluation
      system, we can improve the individualized prevention and treatment of hemophilia in Chinese
      children and achieve precise customization of treatment plans. Rational use of medical
      resources, but also fully achieve the prevention and treatment goals.
    
  